小鼠模型市场：按模型类型、按服务、按技术、按应用、按最终用户、按地区

预计 2025 年小鼠模型市场价值将达到 18.6 亿美元，到 2032 年预计将达到 36 亿美元，2025 年至 2032 年的年复合成长率（CAGR）为 9.9%。

全球小鼠模型市场在更广泛的生物医学研究生态系统中占有重要的地位，是科学发现和药物开发的重要工具。实验室小鼠，尤其是基因转殖小鼠，由于其与人类基因相似、生物系统特征明确、研究通讯协定成熟，已成为临床前研究的黄金标准。该市场涵盖各种小鼠模型，包括近交系和远交系、基因工程模型小鼠 (GEM) 和免疫力缺乏小鼠，每种模型都旨在复製特定的人类疾病和病症。

慢性病、癌症、神经系统疾病和代谢性疾病的增多，推动了对能够准确模拟人类病理生理的先进动物模型的需求。学术机构、製药公司、生技公司和受託研究机构都高度依赖这些模型进行药物研发、毒理学研究、疗效测试和个人化医疗研究。 CRISPR-Cas9 等基因工程技术的进步进一步推动了市场成长。 CRISPR-Cas9 能够开发更精准、特异性疾病的小鼠模型，进而改善研究成果，并加速实验室研究成果向临床应用的转化。

市场动态

全球小鼠模型市场的成长受到多种诱人因素的驱动，这些因素推动了其在製药和生物技术领域的强劲扩张。首先是药物研发活动的指数级成长，药厂越来越依赖复杂的小鼠模型来评估治疗方案的有效性和安全性，然后再进行人体试验。癌症、糖尿病、心血管疾病和神经系统疾病等慢性疾病的发生率上升，使得开发能够准确重现人类病理生理学的疾病特异性小鼠模型成为必要，从而推动了市场需求。

此外，基因工程技术的进步，尤其是 CRISPR-Cas9 和其他基因编辑技术的进步，彻底改变了基因转殖小鼠模型的创建，使研究人员能够开发出更精确、更有针对性的实验系统。然而，该市场面临重大限制因素，威胁其成长轨迹。严格的动物研究法律规范，包括伦理考量和合规要求，为市场扩张设置了障碍，并增加了研究机构的营运成本。对体外模型、器官晶片技术和计算建模等替代测试方法的日益重视，对传统的基于动物的研究模式构成了潜在威胁。此外，培育、维护和饲养特定小鼠品系的高成本，加上对专门设施和训练有素的人员的需求，限制了小型研究机构获得此类研究的便利性。

儘管面临诸多挑战，个人化医疗方法的日益普及（这种方法需要患者特定的小鼠模型来开发客製化治疗方案）正在创造巨大的商机。提供专业小鼠模型服务的受託研究机构的扩张为市场成长提供了有利机会，尤其是在研究基础设施快速发展的新兴市场。

本次调查的主要特点

• 本报告对全球小鼠模型市场进行了详细分析，并以 2024 年为基准年，给出了预测期（2025-2032 年）的市场规模（十亿美元）和年复合成长率（CAGR%）。
• 它还强调了各个领域的潜在商机，并说明了针对该市场的引人注目的投资提案。
• 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景以及主要企业采用的竞争策略的重要见解。
• 它根据公司亮点、产品系列、关键亮点、性能和策略等参数，概述了全球小鼠模型市场的主要企业。
• 本报告的见解将使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
• 本研究报告针对该产业的各个相关人员，包括投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
• 透过用于分析全球小鼠模型市场的各种策略矩阵，相关人员将更容易做出决策。

目录

第 1 章：调查目标与先决条件

• 调查目的
• 先决条件
• 简称

第二章 市场展望

• 报告描述
  • 市场定义和范围
• 执行摘要

第三章：市场动态、法规与趋势分析

• 市场动态
• 驱动程式
• 抑制因素
• 机会
• 影响分析
• 主要进展
• 监管情景
• 产品发布/核准
• PEST分析
• 波特分析
• 併购场景
• 产业趋势

4. 2020 年至 2032 年全球小鼠模型市场（依模型类型）

• 基因工程小鼠（GEM）
• 近交系小鼠
• 杂交小鼠品系
• 杂交/同源小鼠
• 自发突变小鼠

5. 2020-2032 年全球小鼠模型市场（按服务划分）

• 育种服务
• 冷冻保存、重新交付和定序服务
• 基因检测与表征服务
• 体内和体外模型服务
• 客製化模型开发服务

6. 2020-2032 年全球小鼠模型市场（依技术分类）

• CRISPR/Cas9
• 胚胎干细胞（ESC）技术
• 核子移植技术
• 显微注射技术
• 其他（例如 TALEN、ZFN）

7. 2020 年至 2032 年全球小鼠模型市场（按应用）

• 肿瘤学研究
• 免疫学/发炎研究
• 糖尿病研究
• 心血管研究
• 神经疾病研究
• 罕见疾病研究
• 毒性与安全性评估
• 其他（例如代谢紊乱、感染疾病）

8. 全球小鼠模型市场（依最终用户划分），2020-2032 年

• 製药和生物技术公司
• 学术和研究机构
• 合约研究组织（CRO）
• 政府机构和非营利组织

9. 2020-2032 年全球小鼠模型市场（按地区）

• 北美洲
  • 美国
  • 加拿大
• 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
• 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 其他亚太地区
• 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
• 非洲
  • 南非
  • 北非
  • 中部非洲

第十章 竞争格局

• Charles River Laboratories
• The Jackson Laboratory
• Inotiv
• genOway
• Taconic Biosciences
• Janvier Labs
• Crown Bioscience
• Cyagen Biosciences
• GemPharmatech
• Shanghai Model Organisms Center（SMOC）
• Biocytogen
• Ozgene Pty Ltd
• Trans Genic Inc.
• Harbour BioMed
• JSR Life Sciences

第 11 章分析师建议

• 机会
• 分析师观点
• Coherent Opportunity Map

第十二章参考文献与调查方法

• 参考
• 调查方法
• 关于出版商

Mice Model Market is estimated to be valued at USD 1.86 Bn in 2025 and is expected to reach USD 3.60 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.9% from 2025 to 2032.

The global mice model market represents a critical segment within the broader biomedical research ecosystem, serving as an indispensable tool for scientific discovery and pharmaceutical development. Laboratory mice, particularly genetically modified strains, have become the gold standard for preclinical research due to their genetic similarity to humans, well-characterized biological systems, and established research protocols. This market encompasses various mouse models including inbred strains, outbred stocks, Genetically Engineered Models (GEMs), and immunodeficient mice, each designed to replicate specific human diseases and conditions.

The increasing prevalence of chronic diseases, cancer, neurological disorders, and metabolic conditions has intensified the demand for sophisticated animal models that can accurately mimic human pathophysiology. Academic institutions, pharmaceutical companies, biotechnology firms, and contract research organizations heavily rely on these models for drug discovery, toxicology studies, efficacy testing, and personalized medicine research. The market's growth is further propelled by technological advancements in genetic engineering techniques such as CRISPR-Cas9, which enable the development of more precise and disease-specific mouse models, thereby enhancing research outcomes and accelerating the translation of laboratory findings into clinical applications.

Market Dynamics

The global mice model market growth is driven by several compelling factors that collectively fuel its robust expansion across the pharmaceutical and biotechnology sectors. The primary driver stems from the exponential growth in drug discovery and development activities, where pharmaceutical companies increasingly rely on sophisticated mouse models to evaluate therapeutic efficacy and safety profiles before advancing to human trials. The rising prevalence of chronic diseases, including cancer, diabetes, cardiovascular disorders, and neurological conditions, necessitates the development of disease-specific mouse models that can accurately replicate human pathophysiology, thereby driving market demand.

Additionally, technological advancements in genetic engineering, particularly CRISPR-Cas9 and other gene-editing technologies, have revolutionized the creation of genetically modified mouse models, enabling researchers to develop more precise and targeted experimental systems. However, the market faces significant restraints that challenge its growth trajectory. Stringent regulatory frameworks governing animal research, including ethical considerations and compliance requirements, create barriers for market expansion and increase operational costs for research institutions. The growing emphasis on alternative testing methods, such as in-vitro models, organ-on-chip technologies, and computational modeling, poses a potential threat to traditional animal-based research paradigms. Furthermore, the high costs associated with breeding, maintaining, and housing specialized mouse strains, coupled with the need for specialized facilities and trained personnel, limit accessibility for smaller research organizations.

Despite these challenges, substantial opportunities emerge from the increasing adoption of personalized medicine approaches, which require patient-specific mouse models for tailored therapeutic development. The expansion of contract research organizations offering specialized mouse model services presents lucrative opportunities for market growth, particularly in emerging markets where research infrastructure is rapidly developing.

Key Features of the Study

• This report provides in-depth analysis of the global mice model market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global mice model market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Charles River Laboratories, The Jackson Laboratory, Inotiv, genOway, Taconic Biosciences, Janvier Labs, Crown Bioscience, Cyagen Biosciences, GemPharmatech, Shanghai Model Organisms Center (SMOC), Biocytogen, Ozgene Pty Ltd, Trans Genic Inc., Harbour BioMed, and JSR Life Sciences
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global mice model market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global mice model market

Market Segmentation

• Model Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Genetically Engineered Mice (GEM)
  • Knockout Mice
  • Knock-in Mice
  • Conditional Mutant Mice
  • Inbred Mice
  • Outbred Mice
  • Hybrid/Congenic Mice
  • Spontaneous Mutant Mice
• Service Insights (Revenue, USD Bn, 2020 - 2032)
  • Breeding Services
  • Cryopreservation, Rederivation, and Resequencing Services
  • Genetic Testing and Characterization Services
  • Model In-vivo and In-vitro Testing Services
  • Custom Model Development Services
• Technology Insights (Revenue, USD Bn, 2020 - 2032)
  • CRISPR/Cas9
  • Embryonic Stem Cell (ESC) Technology
  • Nuclear Transfer Technology
  • Microinjection Technology
  • Others (e.g., TALENs, ZFNs)
• Application Insights (Revenue, USD Bn, 2020 - 2032)
  • Oncology Research
  • Immunology and Inflammation Studies
  • Diabetes Research
  • Cardiovascular Research
  • Neurological Disease Research
  • Rare Disease Research
  • Toxicology and Safety Assessment
  • Others (e.g., Metabolic Disorders, Infectious Diseases)
• End User Insights (Revenue, USD Bn, 2020 - 2032)
  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutions
  • Contract Research Organizations (CROs)
  • Government and Nonprofit Organizations
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Charles River Laboratories
  • The Jackson Laboratory
  • Inotiv
  • genOway
  • Taconic Biosciences, Inc.
  • Janvier Labs
  • Crown Bioscience
  • Cyagen
  • GemPharmatech
  • Shanghai Model Organisms Center, Inc.
  • Biocytogen
  • Ozgene Pty Ltd
  • Trans Genic Inc.
  • Harbour BioMed
  • JSR Life Sciences, LLC

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Mice Model Market, By Model Type
  • Global Mice Model Market, By Service
  • Global Mice Model Market, By Technology
  • Global Mice Model Market, By Application
  • Global Mice Model Market, By End User
  • Global Mice Model Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Mice Model Market, By Model Type, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Genetically Engineered Mice (GEM)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
    • Knockout Mice
    • Knock-in Mice
    • Conditional Mutant Mice
• Inbred Mice
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Outbred Mice
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Hybrid/Congenic Mice
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Spontaneous Mutant Mice
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Mice Model Market, By Service, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Breeding Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Cryopreservation, Rederivation, and Resequencing Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Genetic Testing and Characterization Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Model In-vivo and In-vitro Testing Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Custom Model Development Services
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Mice Model Market, By Technology, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• CRISPR/Cas9
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Embryonic Stem Cell (ESC) Technology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Nuclear Transfer Technology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Microinjection Technology
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others (e.g., TALENs, ZFNs)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Mice Model Market, By Application, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Oncology Research
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Immunology and Inflammation Studies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Diabetes Research
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Cardiovascular Research
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Neurological Disease Research
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Rare Disease Research
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Toxicology and Safety Assessment
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others (e.g., Metabolic Disorders, Infectious Diseases)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Mice Model Market, By End User, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Pharmaceutical and Biotechnology Companies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Academic and Research Institutions
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Contract Research Organizations (CROs)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Government and Nonprofit Organizations
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Mice Model Market, By Region, 2020 - 2032, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Model Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Service, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Model Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Service, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Model Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Service, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Model Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Service, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Model Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Service, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Model Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Service, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Technology, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

10. Competitive Landscape

• Charles River Laboratories
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• The Jackson Laboratory
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Inotiv
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• genOway
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Taconic Biosciences
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Janvier Labs
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Crown Bioscience
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Cyagen Biosciences
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• GemPharmatech
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Shanghai Model Organisms Center (SMOC)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Biocytogen
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Ozgene Pty Ltd
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Trans Genic Inc.
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Harbour BioMed
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• JSR Life Sciences
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

11. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

12. References and Research Methodology

• References
• Research Methodology
• About us